228 related articles for article (PubMed ID: 26762572)
1. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
[TBL] [Abstract][Full Text] [Related]
2. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
Hompes D; Boot H; van Tinteren H; Verwaal V
J Surg Oncol; 2011 Sep; 104(3):269-73. PubMed ID: 21465492
[TBL] [Abstract][Full Text] [Related]
3. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin.
van Oudheusden TR; Razenberg LG; van Gestel YR; Creemers GJ; Lemmens VE; de Hingh IH
Sci Rep; 2015 Dec; 5():18632. PubMed ID: 26686250
[TBL] [Abstract][Full Text] [Related]
5. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
Zani S; Papalezova K; Stinnett S; Tyler D; Hsu D; Blazer DG
J Surg Oncol; 2013 Mar; 107(4):307-11. PubMed ID: 22811275
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
7. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
[TBL] [Abstract][Full Text] [Related]
8. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy.
Klaver YL; Lemmens VE; Creemers GJ; Rutten HJ; Nienhuijs SW; de Hingh IH
Ann Oncol; 2011 Oct; 22(10):2250-6. PubMed ID: 21345939
[TBL] [Abstract][Full Text] [Related]
9. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.
Hompes D; Aalbers A; Boot H; van Velthuysen ML; Vogel W; Prevoo W; van Tinteren H; Verwaal V
Colorectal Dis; 2014 Aug; 16(8):O264-72. PubMed ID: 24433532
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
11. Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?
Ishida H; Kumamoto K; Ishibashi K; Hatano S; Matsuzawa T; Okada N; Kumagai Y; Baba H; Haga N
Tech Coloproctol; 2013 Dec; 17(6):647-52. PubMed ID: 23389285
[TBL] [Abstract][Full Text] [Related]
12. Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
Legué LM; van Erning FN; Bernards N; Lemmens VEPP; de Hingh IHJT; Creemers GJ
Target Oncol; 2019 Dec; 14(6):699-705. PubMed ID: 31625001
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
15. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.
Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
17. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study.
Razenberg LG; Lemmens VE; Verwaal VJ; Punt CJ; Tanis PJ; Creemers GJ; de Hingh IH
Eur J Cancer; 2016 Sep; 65():113-20. PubMed ID: 27497343
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
Shida D; Yoshida T; Tanabe T; Tsukamoto S; Ochiai H; Kanemitsu Y
Ann Surg Oncol; 2018 Jun; 25(6):1646-1653. PubMed ID: 29572704
[TBL] [Abstract][Full Text] [Related]
19. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
[TBL] [Abstract][Full Text] [Related]
20. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
